相关实验视频

Updated: Jun 5, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

瘤免疫治疗中的PROTAC输送:我们在哪里,我们要去哪里?

Yiyang Li¹, Yike Wu¹, Sihan Gao¹

¹Key Laboratory of Smart Drug DeliveryMinistry of Education, Minhang Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Department of Pharmaceutics, School of Pharmacy, Fudan University, Shanghai 201203, China.

Journal of controlled release : official journal of the Controlled Release Society

|December 5, 2024

概括

化学抗原受体T细胞 (CAR-T) 疗法对血液癌症有希望,但与固体瘤作斗争. 蛋白质溶解向金马 (PROTACs) 提供了一种新的方法,通过降解向蛋白质来增强"冷"瘤的免疫疗法.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
药物发现药物发现药物发现

背景情况:

化学抗原受体T细胞 (CAR-T) 疗法对血液性恶性瘤有效,但在固体瘤中面临挑战.
"冷"瘤表现出较低的T细胞透和免疫反应,阻碍了免疫治疗的有效性.
许多固体瘤标是传统的小分子抑制剂"不可抗药".

研究的目的:

分析导致寒冷瘤免疫治疗反应不佳的因素.
综合用于感冒瘤的免疫疗法策略,重点关注蛋白质溶解向金马 (PROTACs).
在先进的药物输送系统的帮助下,审查PROTACs的开发和临床潜力.

主要方法:

对免疫疗法,感冒瘤和PROTAC技术的现有文献的审查.
分析与PROTACs相关的挑战,包括可溶性,透性和Hook效应.
探索如何先进的药物输送系统可以克服 PROTAC 的局限性.

主要成果:

在感冒瘤中发现免疫疗法耐药性的关键原因.
强调了PROTACs在克服目标可访问性和退化挑战方面的潜力.
证明了药物输送系统在实现PROTAC疗效方面的关键作用.

结论:

需要创新策略来改善感冒瘤的免疫疗法.
PROTACs代表了对感冒瘤的一种有前途的治疗方式,具有临床转化潜力.
对PROTAC输送系统的进一步研究可以显著推进癌症免疫疗法.

关键词:

寒冷的瘤是一个冷的瘤.药物输送系统是药物输送系统.免疫治疗是一种免疫疗法.这就是PROTAC.

更多相关视频

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...